Capricor therapeutics Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

About Capricor therapeutics Contact Number

Contact Information: Capricor Therapeutics. 8840 Wilshire Blvd 2nd Floor Beverly Hills, CA 90211 Tel: +310-358-3200. Careers. Capricor is always searching for highly qualified candidates to join our team. For more information please email us at [email protected] or click here to view a list of available positions.

Contact US: https://capricor.com/contact/

Capricor

23 People Used

See More ››

Capricor Therapeutics

Capricor is Developing Transformative Cell and Exosome-based Therapeutics for the Treatment and prevention of Diseases

View Contact ››

Other

80 People Used

See More ››

Capricor Therapeutics, Inc.

Find the Capricor Therapeutics, Inc. company''s Engineering team/department contact details such as business emails, phone numbers, web address and other …

View Contact ››

Contact

52 People Used

See More ››

Capricor Therapeutics

Contact Email [email protected]capricor.com Phone Number (310) 358-3200 Capricor Therapeutics is a clinical-stage biotechnology company that focuses on the discovery, development, and commercialization of cell and exosome-based therapeutics for the treatment and prevention of diseases.

View Contact ››

CAPRICOR

184 People Used

See More ››

CAPRICOR THERAPEUTICS, INC. (Form: DEF 14A, Received: 04

CAPRICOR THERAPEUTICS, INC. 8840 Wilshire Blvd., 2 nd Floor Beverly Hills, California 90211 Telephone: (310) 358-3200 . NOTICE OF ANNUAL MEETING OF STOCKHOLDERS . To Be Held on June 5, 2020 . Dear Stockholders of Capricor Therapeutics, Inc.:

View Contact ››

Treatment

44 People Used

See More ››

Company Overview

Our Story Capricor Therapeutics, Inc. (Nasdaq: CAPR) is a clinical-stage biotechnology company focused on the discovery, development, and commercialization of first-in-class cell and exosome-based therapeutics for the treatment and prevention of diseases. Our innovative technology builds upon a large body of scientific research and enables us to approach the treatment of diseases in novel ways.

View Contact ››

Exosome-based

38 People Used

See More ››

Investors

To view a complete list of our most recent and past events and presentations please click here. Corporate Overview Capricor Therapeutics, Inc. (NASDAQ: CAPR) is a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class cell and exosome-based therapeutics for the treatment and prevention of diseases. Capricor’s lead candidate, CAP

View Contact ››

ConaKCSA

101 People Used

See More ››

Capricor Therapeutics Signs Exclusive Worldwide License

For more information, please contact: Media Contact:Caitlin Kasunich / Raquel ConaKCSA Strategic [email protected] / [email protected] / 212.896.1204 Investor Contact:Joyce

View Contact ››

PHASE

46 People Used

See More ››

Clinical Trials

ALLSTAR PHASE I completed PHASE II enrollment complete. The ALLogeneic Heart STem Cells to Achieve Myocardial Regeneration (ALLSTAR) trial is a Phase I/II trial evaluating the safety and efficacy of lead therapeutic candidate, CAP-1002 – Capricor’s allogeneic, off-the-shelf, cardiosphere-derived cell product.. Read More…

View Contact ››

Bergmann

53 People Used

See More ››

Capricor Therapeutics

AJ Bergmann, Chief Financial OfficerLos Angeles, CA(NASDAQ: CAPR)

View Contact ››

Linda

54 People Used

See More ››

Capricor Therapeutics

Linda Marban, Ph.D., President and CEOLos Angeles, CA(NASDAQ: CAPR)Capricor Therapeutics is a clinical-stage biotechnology company developing biological ther

View Contact ››

Please leave your comments here:

Popular Brands

Cnooc
Cae
Cerner
Crh
Csi